BioTek’s Adam Alpert named to Government Modernization and Efficiency Team

Alpert will bring expertise in strategic budgeting, which was used to expand BioTek’s global leadership and success in life-sciences instrumentation
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
WINOOSKI Vt.—BioTek Instruments announced March 13 that Vice President Adam Alpert was named a member of Vermont Gov. Phil Scott’s Government Modernization and Efficiency Team (GMET). This team, comprised of twelve individuals from inside and outside state government, will advise on strategic initiatives towards improving efficiencies and outcomes throughout Vermont’s government. Ultimately, the team’s recommendations will support the governor’s goals of making Vermont more affordable and strengthening the economy in the modern era.
 
Alpert will bring particular expertise to the team in the form of a strategic budgeting model, which was used to expand BioTek’s global leadership and success in the life-sciences instrumentation market over the past decade. He echoed the governor’s goals, noting, “To the extent that we can grow the economy, make Vermont more affordable, and protect the most vulnerable; the prospect for healthy, prosperous Vermonters is much more likely to be realized. Personally, I can’t imagine a more satisfying effort.”
 
Scott added, “I’m grateful to Adam for lending his time and expertise to my Government Modernization and Efficiency Team and for the work he and the team will be doing to bring state government into the 21st century to improve service and outcomes for Vermonters.”
 
BioTek Instruments is a global leader in the design, manufacture and distribution of innovative life-sciences instrumentation. Itscomprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life-sciences research by providing high-performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications.
 

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue